Peer-reviewedCC BY-NC-ND 4.0Communications Medicine
Exploiting iron metabolism in Ewing sarcoma
Abstract
Ewing sarcoma is an aggressive bone cancer of children and young adults. Survivors face long-term complications from intensive chemotherapy and outcomes remain stubbornly poor for patients with metastases. There is an urgent need for improved treatments. Emerging evidence suggests Ewing sarcoma is particularly sensitive to perturbed iron homeostasis. As iron contributes to many critical processes, there are multiple mechanisms to disrupt iron metabolism. Several pre-clinical studies exploiting altered iron homeostasis in Ewing sarcoma report encouraging results. This review summarizes unique features of and ways to target iron metabolism in Ewing sarcoma, and the translational potential for these therapeutic strategies.
Related
- Fatal complications in a young adult with large Ewing sarcoma of the chest wall
- From the Thoracic Outlet to the Brachial Plexus: A Rare Presentation of Pediatric Ewing Sarcoma
- Targeting GPX4 and FSP1 to exploit ferroptotic vulnerability in Ewing sarcoma
- 220 Overcoming antigen heterogeneity in Ewing sarcoma using adaptable multi-targeted SNAP-CAR T cells
- Primary renal Ewing sarcoma with extensive metastatic disease at diagnosis: A case report and literature review
BibTeX
@article{hayes2026exploiting,
title = {{Exploiting iron metabolism in Ewing sarcoma}},
author = {Colin M. Hayes and Emily R. Theisen},
journal = {Communications Medicine},
year = {2026},
month = oct,
doi = {10.1038/s43856-026-01954-3},
url = {https://www.nature.com/articles/s43856-026-01954-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Exploiting iron metabolism in Ewing sarcoma
AU - Colin M. Hayes
AU - Emily R. Theisen
PY - 2026
DA - 2026/10/28
JO - Communications Medicine
DO - 10.1038/s43856-026-01954-3
UR - https://www.nature.com/articles/s43856-026-01954-3
AB - Ewing sarcoma is an aggressive bone cancer of children and young adults. Survivors face long-term complications from intensive chemotherapy and outcomes remain stubbornly poor for patients with metastases. There is an urgent need for improved treatments. Emerging evidence suggests Ewing sarcoma is particularly sensitive to perturbed iron homeostasis. As iron contributes to many critical processes, there are multiple mechanisms to disrupt iron metabolism. Several pre-clinical studies exploiting altered iron homeostasis in Ewing sarcoma report encouraging results. This review summarizes unique features of and ways to target iron metabolism in Ewing sarcoma, and the translational potential for these therapeutic strategies.
SN - 2730-664X
ER -